Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...

OXFORD — The New York Giants have given Ole Miss football quarterback Jaxson Dart a chance to break more of Eli Manning's records. The Giants selected Dart with the No. 25 pick in the first ...

As NFL media goes, few are more respected and admired than Peter King. He retired last year, but he retains a part-time presence in the broader pro football ecosystem. And when he speaks, people ...

When I stopped attending my Latter-day Saint ward in 2014, I never really had any intention of going through the formal process of coordinating with corporate to cancel my relationship with God.

He also spoke about his estranged relationship with his family, revealing the King won't "speak to him". But could they reconcile? On today's Sky News Daily, Matt Barbet speaks to royal ...

Eagles cornerback Eli Ricks stirred controversy during the team's White House visit by publicly expressing his admiration for Ivanka Trump on social media. His tweets, complimenting her appearance ...

In JPMorgan's view, CVS's move "will likely impact only a small portion of Eli Lilly's Zepbound business," and the bank therefore believes Lilly stock will still outperform the market. Investment ...

Eli Lilly said the revision reflects a $1.57 billion deal charge recorded in the first quarter, which is primarily related to its acquisition of a certain oral cancer drug from Scorpion Therapeutics.

King Charles shared a touching update in his ongoing fight against cancer and what he’s learned from his diagnosis. The king wrote a message that was printed in a booklet and handed out during ...

Eli Lilly (NYSE: NYSE:LLY) is set to report its first-quarter earnings on Thursday, May 1st, before the market opens. Analysts expect the drugmaker to earn $3.46 (+34.1% Y/Y) on revenue of $12.72B ...

Positive results for Eli Lilly's new diabetes and weight-loss drug have recently boosted its stock price. Data from several studies on the GLP-1 drug are expected to come out this year.

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting results tomorrow before market hours. Here’s what to look for. Eli Lilly met analysts’ revenue expectations last quarter ...